Merck (BUE:MRK) SpecialCharges

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BUE:MRK Merck & Co Inc BUE:MRK
76 GF Score
Price ARS40,620.00
GF Value ARS36,798.91
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Merck SpecialCharges?

Special Charges only applies to banks.

BUE:MRK
76GF Score
Merck & Co Inc BUE:MRK
SpecialCharges is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Merck (BUE:MRK) Overvalued in 2026?

Based on GuruFocus' analysis, Merck stock appears to be overvalued. The current stock price of ARS40,620.00 is trading 10.4% above its estimated GF Value™ of ARS36,798.91. GuruFocus considers Merck to be Fairly Valued.

Key valuation signals for BUE:MRK:

  • SpecialCharges:
  • GF Value™: ARS36,798.91 vs. price of ARS40,620.00 (10.4% above fair value)
  • GF Score™: 76/100 with 10 warning signs

No single metric tells the full story. See the BUE:MRK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Merck Business Description

Address 126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
76GF Score

Get the complete analysis for BUE:MRK

SpecialCharges is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

ARS40,620.00
Price
ARS36,798.91
GF Value